SEC Form 4 · accession 0001209191-15-008488
IMMUNOMEDICS INC · IMMU
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David M Goldenberg
Officer — CSO & Chairman of the BOD · Director · 10% Owner
Period of report
Jan 29, 2015
Accepted (ET)
Feb 2, 2015 · 9:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000722830
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 29, 2015 | A | 58,480 | $0.00 | A | 2,582,159 | D | |
| Common Stock | Jan 29, 2015 | F | 21,963 | $5.28 | D | 2,560,196 | D | |
| Common StockF1,F3 | Jan 29, 2015 | A | 58,479 | $0.00 | A | 3,225,745 | I | See Footnote |
| Common StockF3 | Jan 29, 2015 | F | 21,935 | $5.28 | D | 3,203,810 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Such Performance Units represent the settlement of common stock underlying Performance Units that have vested in accordance with the terms of the Performance-Based Restricted Stock Unit Issuance Agreement.
- F2Includes a total of 190,000 shares held as joint tenants by the reporting person and his spouse.
- F3Such shares are held by the reporting person's spouse, by various trusts established for the benefit of the reporting person and/or family members of the reporting person, or by a majority-owned subsidiary of the Issuer, of which the reporting person is a director. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interests therein.